Colorado Protein Stability Conference
August 3–6, 2026, Breckenridge, CO, USA
Meet Coriolis Pharma at the Colorado Protein Stability Conference 2026. The Conference brings together experts to discuss the latest insights into protein stability, degradation mechanisms, and analytical approaches.
We are excited to contribute to the scientific program with a presentation by Tim Menzen:
August 4 at 5:25 pm – To platform or not to platform: strategic considerations for antibody formulation in early clinical development.
In addition our experts will present three different posters on most relevant topics:
- Formulation and Freezing Effects in Lyophilized Viral Vaccines
(Brecht Vanbillemont) - Analytical strategy to monitor surfactant integrity by LC-based methods and orthogonal particle characterization
(Amber Raines) - A novel in silico platform combining data-driven and physics-based models for protein formulation developability assessment
(Tim Menzen)
Together, these contributions showcase Coriolis Pharma’s expertise in formulation development, analytical characterization, and stability sciences across a wide range of biologic drug products. Visit our booth to meet our experts and discuss how our science-driven approach helps accelerate and de-risk drug product development.
More Events
On-Demand Webinars
March 3, 2025
Developability Assessment and Early Formulation Studies for Biologics
